1. Wardlaw J, Smith E, Biessels G, Cordonnier C, Fazekas F, Frayne R, Lindley R, O'Brien J, Barkhof F, Benavente O, Black S, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw F, Doubal F, Duering M, Fox N, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge R, Pantoni L, Speck O, Stephan B, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick P, Dichgans M (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology 12 (8):822-838. doi:10.1016/s1474-4422(13)70124-8
2. Liu Y, Braidy N, Poljak A, Chan D, Sachdev P (2018) Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review. Ageing research reviews 47:41-48. doi:10.1016/j.arr.2018.06.002
3. van Sloten T, Sigurdsson S, van Buchem M, Phillips C, Jonsson P, Ding J, Schram M, Harris T, Gudnason V, Launer L (2015) Cerebral Small Vessel Disease and Association With Higher Incidence of Depressive Symptoms in a General Elderly Population: The AGES-Reykjavik Study. The American journal of psychiatry 172 (6):570-578. doi:10.1176/appi.ajp.2014.14050578
4. AK D, V S, G T, SE B, B L (2016) Pathoconnectomics of cognitive impairment in small vessel disease: A systematic review. Alzheimer's & dementia : the journal of the Alzheimer's Association 12 (7):831-845
5. CC L, WX C, J W, M X, ZC J, C G, XQ T, MX L, Y Y, X L, H F (2020) Nicotinamide riboside rescues angiotensin II-induced cerebral small vessel disease in mice. CNS Neurosci Ther 26 (4):438-447. doi:10.1111/cns.13276
6. Xu M, Li B, Zhong D, Cheng Y, Wu Q, Zhang S, Zhang S, Wu B, Liu M (2021) Cerebral Small Vessel Disease Load Predicts Functional Outcome and Stroke Recurrence After Intracerebral Hemorrhage: A Median Follow-Up of 5 Years. Front Aging Neurosci 13:628271. doi:10.3389/fnagi.2021.628271
7. Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF (2019) CNS small vessel disease: A clinical review. Neurology 92 (24):1146-1156. doi:10.1212/WNL.0000000000007654
8. Wang Y, Jiang Y, Suo C, Yuan Z, Xu K, Yang Q, Tang W, Zhang K, Zhu Z, Tian W, Fan M, Li S, Ye W, Dong Q, Jin L, Cui M, Chen X (2019) Deep/mixed cerebral microbleeds are associated with cognitive dysfunction through thalamocortical connectivity disruption: The Taizhou Imaging Study. NeuroImage Clinical 22:101749. doi:10.1016/j.nicl.2019.101749
9. Rajani RM, Quick S, Ruigrok SR, Graham D, Harris SE, Verhaaren BFJ, Fornage M, Seshadri S, Atanur SS, Dominiczak AF, Smith C, Wardlaw JM, Williams A (2018) Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats. Sci Transl Med 10 (448). doi:10.1126/scitranslmed.aam9507
10. NJ A, L R, E H (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nature reviews Neuroscience 7 (1):41-53
11. Tarantini S, Valcarcel-Ares MN, Toth P, Yabluchanskiy A, Tucsek Z, Kiss T, Hertelendy P, Kinter M, Ballabh P, Sule Z, Farkas E, Baur JA, Sinclair DA, Csiszar A, Ungvari Z (2019) Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice. Redox Biol 24:101192. doi:10.1016/j.redox.2019.101192
12. Sweeney M, Sagare A, Zlokovic B (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nature reviews Neurology 14 (3):133-150. doi:10.1038/nrneurol.2017.188
13. Dikalova AE, Pandey A, Xiao L, Arslanbaeva L, Sidorova T, Lopez MG, Billings FTt, Verdin E, Auwerx J, Harrison DG, Dikalov SI Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stress. (1524-4571 (Electronic))
14. Chen W, Guo C, Jia Z, Wang J, Xia M, Li C, Li M, Yin Y, Tang X, Chen T, Hu R, Chen YA-O, Liu XA-O, Feng HA-O Inhibition of Mitochondrial ROS by MitoQ Alleviates White Matter Injury and Improves Outcomes after Intracerebral Haemorrhage in Mice. (1942-0994 (Electronic))
15. Oldendorf W, Cornford M, Brown W (1977) The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol 1 (5):409-417. doi:10.1002/ana.410010502
16. Kadlec A, Beyer A, Ait-Aissa K, Gutterman D (2016) Mitochondrial signaling in the vascular endothelium: beyond reactive oxygen species. Basic Res Cardiol 111 (3):26. doi:10.1007/s00395-016-0546-5
17. Kluge MA, Fetterman Jl Fau - Vita JA, Vita JA Mitochondria and endothelial function. (1524-4571 (Electronic))
18. Parton R, del Pozo M (2013) Caveolae as plasma membrane sensors, protectors and organizers. Nature reviews Molecular cell biology 14 (2):98-112. doi:10.1038/nrm3512
19. Filippini A, D'Alessio A (2020) Caveolae and Lipid Rafts in Endothelium: Valuable Organelles for Multiple Functions. Biomolecules 10 (9). doi:10.3390/biom10091218
20. Andreone BJ, Chow BW, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C (2017) Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron 94 (3):581-594 e585. doi:10.1016/j.neuron.2017.03.043
21. Liu P, Rudick M Fau - Anderson RGW, Anderson RG Multiple functions of caveolin-1. (0021-9258 (Print))
22. BW C, V N, L K, AJ G, K B, HL Z, P K, BL S, C G (2020) Caveolae in CNS arterioles mediate neurovascular coupling. Nature 579 (7797):106-110. doi:10.1038/s41586-020-2026-1
23. Bonds JA, Shetti A, Bheri A, Chen Z, Disouky A, Tai L, Mao M, Head BP, Bonini MG, Haus JM, Minshall RD, Lazarov O (2019) Depletion of Caveolin-1 in Type 2 Diabetes Model Induces Alzheimer's Disease Pathology Precursors. J Neurosci
24. J E, JM S, W C, E P, A S, B A, AE Z-H, MJ F-P, CD M, DM R, HH P, PM P, BP H (2017) Neuron-specific caveolin-1 overexpression improves motor function and preserves memory in mice subjected to brain trauma. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 31 (8):3403-3411. doi:10.1096/fj.201601288RRR
25. Y G, Y Z, J P, L Y, T H, X F, C L, S L, D Z, C L, F T, C T, X C (2014) Treadmill exercise promotes angiogenesis in the ischemic penumbra of rat brains through caveolin-1/VEGF signaling pathways. Brain Res 1585:83-90. doi:10.1016/j.brainres.2014.08.032
26. Ramírez CM, Zhang X, Bandyopadhyay C, Rotllan N, Sugiyama MG, Aryal B, Liu X, He S, Kraehling JR, Ulrich V, Lin CS, Velazquez H, Lasunción MA, Li G, Suárez Y, Tellides G, Swirski FK, Lee WL, Schwartz MA, Sessa WC, Fernández-Hernando C Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation. (1524-4539 (Electronic))
27. Iadecola C, Gottesman RF Neurovascular and Cognitive Dysfunction in Hypertension. (1524-4571 (Electronic))
28. Bravo-Sagua R, Parra V, Ortiz-Sandoval C, Navarro-Marquez M, Rodríguez A, Diaz-Valdivia N, Sanhueza C, Lopez-Crisosto C, Tahbaz N, Rothermel B, Hill J, Cifuentes M, Simmen T, Quest A, Lavandero S (2019) Caveolin-1 impairs PKA-DRP1-mediated remodelling of ER-mitochondria communication during the early phase of ER stress. Cell Death Differ 26 (7):1195-1212. doi:10.1038/s41418-018-0197-1
29. DM Y, SH J, HT A, S L, J H, JS P, H L, H L, MS B, HC L, NK H, J K, JS L, YG K (2017) Caveolin-1 deficiency induces premature senescence with mitochondrial dysfunction. Aging cell 16 (4):773-784
30. Copenhaver B, Hsia A, Merino J, Burgess R, Fifi J, Davis L, Warach S, Kidwell C (2008) Racial differences in microbleed prevalence in primary intracerebral hemorrhage. Neurology 71 (15):1176-1182. doi:10.1212/01.wnl.0000327524.16575.ca
31. Smallwood A, Oulhaj A, Joachim C, Christie S, Sloan C, Smith AD, Esiri M (2012) Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 38 (4):337-343. doi:10.1111/j.1365-2990.2011.01221.x
32. Pasi M, Charidimou A, Boulouis G, Auriel E, Ayres A, Schwab KM, Goldstein JN, Rosand J, Viswanathan A, Pantoni L, Greenberg SM, Gurol ME Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk. (1526-632X (Electronic))
33. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Yusoff FBM, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y (2017) Endothelial Function Is Impaired in Patients Receiving Antihypertensive Drug Treatment Regardless of Blood Pressure Level: FMD-J Study (Flow-Mediated Dilation Japan). Hypertension 70 (4):790-797. doi:10.1161/HYPERTENSIONAHA.117.09612
34. HM J, WM vdF, EL A, CE T, RE J, MP W, P S, MI G, PG K, M M (2015) Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy. Journal of Alzheimer's disease : JAD 44 (1):153-162
35. P A, O B, LB G, A C, H S, MG H, S G, AE R, L S, JA Z, KM W (2009) Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke 40 (4):1405-1409. doi:10.1161/strokeaha.108.534107
36. PM B, JM W (2015) Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. International journal of stroke : official journal of the International Stroke Society 10 (4):469-478
37. S P, RG H, LA P, OR B (2012) Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials. Stroke 43 (8):2157-2162. doi:10.1161/strokeaha.112.656173
38. J E, A Z-H, CD M, IR N, LV L, AM K, DM R, HH P, PM P, BP H (2018) Neuron-Targeted Caveolin-1 Promotes Ultrastructural and Functional Hippocampal Synaptic Plasticity. Cerebral cortex (New York, NY : 1991) 28 (9):3255-3266. doi:10.1093/cercor/bhx196
39. Wardlaw J, Smith C, Dichgans M (2013) Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. The Lancet Neurology 12 (5):483-497. doi:10.1016/s1474-4422(13)70060-7
40. Forrester SJ, Elliott KJ, Kawai T, Obama T, Boyer MJ, Preston KJ, Yan Z, Eguchi S, Rizzo V (2017) Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II. Hypertension 69 (1):79-86. doi:10.1161/HYPERTENSIONAHA.116.08278
41. Xia M, Chen W, Wang J, Yin Y, Guo C, Li C, Li M, Tang X, Jia Z, Hu R, Liu X, Feng H (2019) TRPA1 Activation-Induced Myelin Degradation Plays a Key Role in Motor Dysfunction After Intracerebral Hemorrhage. Front Mol Neurosci 12:98. doi:10.3389/fnmol.2019.00098
42. RM D (2006) Assessing nest building in mice. Nat Protoc 1 (3):1117-1119. doi:10.1038/nprot.2006.170